Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03532581 · ClinicalTrials.gov registry record · NA

Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery

A NA study, sponsored by Ohio State University Comprehensive Cancer Center.

Completed
Registry status
NA
Development phase
48
Enrollment target

NCT03532581: Completed NA study, sponsored by Ohio State University Comprehensive Cancer Center.

NCT03532581 is a NA study that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 48 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03532581, a NA study, has completed, sponsored by Ohio State University Comprehensive Cancer Center.

COMPLETED
Registry status
NA
Development phase
48 participants
Enrollment target

Study Summary

This phase I trial studies how well indocyanine green lymphangiography works in identifying thoracic duct during neck surgery. Diagnostic procedures, such as near infrared fluorescence imaging with indocyanine green may help recognize and prevent injury to thoracic duct during neck surgery.

Primary Outcome

We will determine in how many patients the thoracic duct is identified by white light visualization and by ICG fluorescence. The collected data will be primarily qualitative as determined by the surgeon.

Interventions

  • PROCEDURE Lymphangiography
  • OTHER Indocyanine Green Solution

Trial Details

FieldValue
Enrollment Target 48 participants
Start Date 2018-04-23
Est. Completion 2023-03-07
Phase NA

What the finished NCT03532581 record still lists

NCT03532581 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 48 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).

The record links to 0 conditions, and to 2 interventions - of which Lymphangiography is the first listed.

NCT03532581 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03532581 about?

NCT03532581 is a clinical study titled "Indocyanine Green Lymphangiography in Identifying Thoracic Duct During Neck Surgery". This phase I trial studies how well indocyanine green lymphangiography works in identifying thoracic duct during neck surgery. Diagnostic procedures, such as near infrared fluorescence imaging with indocyanine green may help recognize and prevent injury to thoracic duct during neck surgery.

What is the current status of trial NCT03532581?

This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2018-04-23. Estimated completion is 2023-03-07.

What interventions are being tested in trial NCT03532581?

The interventions under investigation include: Lymphangiography (PROCEDURE), Indocyanine Green Solution (OTHER).

Who is sponsoring clinical trial NCT03532581?

This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03532581's enrollment target sits among peer trials

48 1381st of 2000 higher than 601 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01765777 · 48 participants · NA

    Efficacy of Osteopathic Manipulative Medicine (OMM) and Phototherapy for Patients With Chronic Lower Back Pain

  • NCT03073343 · 48 participants · NA

    A Prospective, Randomized, Open Label Trial of Two Doses of Oral Betaine

  • NCT03431064 · 48 participants

    Lung Recruitment Maneuver as a Potential Predictor of Fluid Responsiveness in Mechanically Ventilated Pediatric Patients

  • NCT03514602 · 48 participants · NA

    Maternal Smoking Cessation and Pediatric Obesity Prevention

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03532581, the US trial registry maintained by the National Library of Medicine. NCT03532581 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.